November 27, 2024
Enterics for Global Health (EFGH) Symposium hosted at the American Society of Tropical Medicine & Hygiene annual meeting
The symposium was titled: “Preliminary results from The Enterics for Global Health (EFGH) Shigella surveillance study- preparing for Shigella vaccine trials in the target population of young children living in low- and middle-income countries” and aimed to:
- Sensitize the audience to the rationale for the EFGH study and need for Shigella vaccines in the target population of young children living in low- and middle-income countries,
- Equip participants with recent data directly applicable to optimally designing Shigella vaccine trials, and
- Outline key short- and long-term consequences of Shigella diarrhea and identify outstanding data that will be critical to policy maker decision-making around eventual adoption of a Shigella vaccine.
Representatives from each of the 7 implementing sites (Bangladesh, Pakistan, Peru, Malawi, Kenya, The Gambia, and Mali) presented preliminary results from the EFGH study including serotype-specific Shigella incidence rates, antimicrobial resistance burden among Shigella isolates collected in EFGH, and estimated costs of Shigella diarrhea.
The symposium was co-Chaired by Dr. Firdausi Qadri of icddr,b and Dr. Patricia Pavlinac, Assistant Professor in the Department of Global Health and Global WACh Co-Director.